PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in women worldwide. Recent advances in the field of immuno-oncology demonstrate the beneficial immunostimulatory effects of the induction of immunogenic cell death (ICD). ICD increases tumor infiltration by T c...
Main Authors: | Kenny Misael Calvillo-Rodríguez, Rodolfo Mendoza-Reveles, Luis Gómez-Morales, Ashanti Concepción Uscanga-Palomeque, Philippe Karoyan, Ana Carolina Martínez-Torres, Cristina Rodríguez-Padilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2022.2054305 |
Similar Items
-
PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis
by: Yun He, et al.
Published: (2022-12-01) -
Relationship of thrombospondin-1 and thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients
by: Dogan Serdar, et al.
Published: (2023-06-01) -
Research progress on the role of thrombospondin 2 in malignant tumors
by: MA Jiajunyan, RUI Tiannan, ZHANG Yongsheng
Published: (2023-12-01) -
Thrombospondin-1 induction and VEGF reduction by proteasome inhibition
by: Fawzia Bardag-Gorce, et al.
Published: (2023-02-01) -
Thrombospondin‐1 Regulates Trophoblast Necroptosis via NEDD4‐Mediated Ubiquitination of TAK1 in Preeclampsia
by: Haoyue Hu, et al.
Published: (2024-06-01)